(Total Views: 263)
Posted On: 12/07/2022 12:45:49 PM
Post# of 190

$PFE News Article - U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults https://marketwirenews.com/news-releases/u-s-...95358.html


My Twitter: WhyteStocks